AN OPEN-LABEL, SINGLE-TREATMENT, SINGLE-PERIOD, SINGLE DOSE, PHASE 1 CLINICAL STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF HAEMOPHILUS TYPE B CONJUGATE VACCINE OF M/s CADILA HEALTHCARE LTD., INDIA IN HEALTHY, ADULT, MALE, HUMAN SUBJECTS UNDER FASTING CONDITION
Latest Information Update: 12 Nov 2019
At a glance
- Drugs Hib vaccine conjugate (Primary)
- Indications Haemophilus infections
- Focus Adverse reactions
- Sponsors Cadila Healthcare
- 23 Oct 2015 Status changed to completed.
- 19 Feb 2014 New trial record